Half-year report · HY

Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥62.4bn2025-07-01 → 2025-12-31Cons.Net sales
Revenue¥122.7bn2024-07-01 → 2025-06-30Cons.Net sales (5-year summary)
Revenue¥60.6bn2024-07-01 → 2024-12-31Cons.Net sales
Operating income¥674m2025-07-01 → 2025-12-31Cons.Operating income
Operating income¥808m2024-07-01 → 2024-12-31Cons.Operating income
Ordinary income¥675m2025-07-01 → 2025-12-31Cons.Ordinary income
Ordinary income¥2.0bn2024-07-01 → 2025-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥824m2024-07-01 → 2024-12-31Cons.Ordinary income
Profit before tax¥695m2025-07-01 → 2025-12-31Cons.Income before income taxes
Profit before tax¥816m2024-07-01 → 2024-12-31Cons.Income before income taxes
Net income (owners)¥451m2025-07-01 → 2025-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.4bn2024-07-01 → 2025-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥648m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income¥451m2025-07-01 → 2025-12-31Cons.Profit loss
Net income¥648m2024-07-01 → 2024-12-31Cons.Profit loss
Total assets¥48.1bnat 2025-12-31Cons.Assets
Total assets¥45.9bnat 2025-06-30Cons.Assets
Total assets¥46.8bnat 2024-12-31Cons.Total assets (5-year summary)
Total liabilities¥36.0bnat 2025-12-31Cons.Liabilities
Total liabilities¥33.6bnat 2025-06-30Cons.Liabilities
Net assets / equity¥12.2bnat 2025-12-31Cons.Net assets
Net assets / equity¥12.3bnat 2025-06-30Cons.Net assets
Net assets / equity¥11.5bnat 2024-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2025-12-31Cons.Cash and deposits
Cash and deposits¥3.5bnat 2025-06-30Cons.Cash and deposits
Cash & equivalents¥2.9bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.4bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.7bnat 2024-06-30vCons.Cash and cash equivalents
Operating cash flow−¥772m2025-07-01 → 2025-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.6bn2024-07-01 → 2025-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥800m2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥977m2025-07-01 → 2025-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.6bn2024-07-01 → 2025-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥889m2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥1.2bn2025-07-01 → 2025-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥687m2024-07-01 → 2025-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.5bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥76.022025-07-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥241.432024-07-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥109.442024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio25.3%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.7%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio24.6%at 2024-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2025-07-01 → 2025-12-31−¥966m
Reconciling Itemsreconcilingrevenue intersegment2025-07-01 → 2025-12-31−¥966m
Reconciling Itemsreconcilingsegment profit2025-07-01 → 2025-12-31−¥68m
Care Nursing Goodsreportable segmentrevenue2025-07-01 → 2025-12-31¥1.5bn
Care Nursing Goodsreportable segmentrevenue external2025-07-01 → 2025-12-31¥1.5bn
Care Nursing Goodsreportable segmentrevenue intersegment2025-07-01 → 2025-12-31¥114,000
Care Nursing Goodsreportable segmentsegment profit2025-07-01 → 2025-12-31¥122m
Medical Equipmentreportable segmentrevenue2025-07-01 → 2025-12-31¥58.9bn
Medical Equipmentreportable segmentrevenue external2025-07-01 → 2025-12-31¥58.0bn
Medical Equipmentreportable segmentrevenue intersegment2025-07-01 → 2025-12-31¥900m
Medical Equipmentreportable segmentsegment profit2025-07-01 → 2025-12-31¥555m
SPDreportable segmentrevenue2025-07-01 → 2025-12-31¥3.0bn
SPDreportable segmentrevenue external2025-07-01 → 2025-12-31¥3.0bn
SPDreportable segmentrevenue intersegment2025-07-01 → 2025-12-31¥66m
SPDreportable segmentsegment profit2025-07-01 → 2025-12-31¥64m
Total Of Reportable Segments And Otherssegment totalrevenue2025-07-01 → 2025-12-31¥63.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-07-01 → 2025-12-31¥62.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-07-01 → 2025-12-31¥966m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-07-01 → 2025-12-31¥742m
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥880m
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥880m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥67m
Care Nursing Goodsreportable segmentrevenue2024-07-01 → 2024-12-31¥1.4bn
Care Nursing Goodsreportable segmentrevenue external2024-07-01 → 2024-12-31¥1.4bn
Care Nursing Goodsreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥19,000
Care Nursing Goodsreportable segmentsegment profit2024-07-01 → 2024-12-31¥105m
Medical Equipmentreportable segmentrevenue2024-07-01 → 2024-12-31¥57.3bn
Medical Equipmentreportable segmentrevenue external2024-07-01 → 2024-12-31¥56.5bn
Medical Equipmentreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥816m
Medical Equipmentreportable segmentsegment profit2024-07-01 → 2024-12-31¥715m
SPDreportable segmentrevenue2024-07-01 → 2024-12-31¥2.8bn
SPDreportable segmentrevenue external2024-07-01 → 2024-12-31¥2.8bn
SPDreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥64m
SPDreportable segmentsegment profit2024-07-01 → 2024-12-31¥55m
Total Of Reportable Segments And Otherssegment totalrevenue2024-07-01 → 2024-12-31¥61.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-07-01 → 2024-12-31¥60.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-07-01 → 2024-12-31¥880m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-07-01 → 2024-12-31¥875m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 534
ItemContextValueUnit
Comprehensive incomePrior1InterimDuration643619000JPY
Comprehensive incomeInterimDuration386984000JPY
Comprehensive income attributable to owners of the parentPrior1InterimDuration643619000JPY
Comprehensive income attributable to owners of the parentInterimDuration386984000JPY
Comprehensive income attributable to non controlling interestsPrior1InterimDuration-JPY
Comprehensive income attributable to non controlling interestsInterimDuration-JPY
Income before income taxesPrior1InterimDuration815698000JPY
Income before income taxesInterimDuration694509000JPY
Depreciation and amortization ope cfPrior1InterimDuration289133000JPY
Depreciation and amortization ope cfInterimDuration350953000JPY
Amortization of goodwill ope cfPrior1InterimDuration3832000JPY
Amortization of goodwill ope cfInterimDuration-JPY
Impairment loss ope cfPrior1InterimDuration11132000JPY
Impairment loss ope cfInterimDuration-JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1InterimDuration-1977000JPY
Increase decrease in allowance for doubtful accounts ope cfInterimDuration7603000JPY
Increase decrease in net defined benefit asset ope cfPrior1InterimDuration-29899000JPY
Increase decrease in net defined benefit asset ope cfInterimDuration-35519000JPY
Increase decrease in net defined benefit liability ope cfPrior1InterimDuration19485000JPY
Increase decrease in net defined benefit liability ope cfInterimDuration16748000JPY
Increase decrease in provision for directors retirement benefits ope cfPrior1InterimDuration1226000JPY
Increase decrease in provision for directors retirement benefits ope cfInterimDuration-2450000JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfPrior1InterimDuration24167000JPY
Increase decrease in provision for share based remuneration for directors and other officers ope cfInterimDuration23163000JPY
Interest and dividends income ope cfPrior1InterimDuration-1730000JPY
Interest and dividends income ope cfInterimDuration-2714000JPY
Compensation income ope cfPrior1InterimDuration-5000000JPY
Compensation income ope cfInterimDuration-JPY
Interest expenses ope cfPrior1InterimDuration16189000JPY
Interest expenses ope cfInterimDuration27006000JPY
Loss gain on sales of investment securities ope cfPrior1InterimDuration-JPY
Loss gain on sales of investment securities ope cfInterimDuration-99000JPY
Foreign exchange losses gains ope cfPrior1InterimDuration-15349000JPY
Foreign exchange losses gains ope cfInterimDuration-21235000JPY
Loss gain on sales of property plant and equipment ope cfPrior1InterimDuration-461000JPY
Loss gain on sales of property plant and equipment ope cfInterimDuration-20524000JPY
Loss on retirement of property plant and equipment ope cfPrior1InterimDuration2896000JPY
Loss on retirement of property plant and equipment ope cfInterimDuration1519000JPY
Loss on retirement of intangible assets ope cfPrior1InterimDuration-JPY
Loss on retirement of intangible assets ope cfInterimDuration82000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1InterimDuration-1711736000JPY
Decrease increase in notes and accounts receivable trade ope cfInterimDuration-1309494000JPY
Decrease increase in inventories ope cfPrior1InterimDuration-1147550000JPY
Decrease increase in inventories ope cfInterimDuration-978826000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1InterimDuration2216345000JPY
Increase decrease in notes and accounts payable trade ope cfInterimDuration1137074000JPY
Increase decrease in long term accounts payable other ope cfPrior1InterimDuration-JPY
Increase decrease in long term accounts payable other ope cfInterimDuration1187000JPY
Other net ope cfPrior1InterimDuration-588153000JPY
Other net ope cfInterimDuration-172130000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-06-30pass
balance sheet identityconsolidated 2025-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2025-07-01/2025-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2025-07-01/2025-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2025-07-01/2025-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass